These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 22044287)

  • 21. Angelica keiskei Koidzumi extracts improve some markers of liver function in habitual alcohol drinkers: a randomized double-blind clinical trial.
    Noh HM; Ahn EM; Yun JM; Cho BL; Paek YJ
    J Med Food; 2015 Feb; 18(2):166-72. PubMed ID: 25531033
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The ratio of aspartate aminotransferase to alanine aminotransferase: potential value in differentiating nonalcoholic steatohepatitis from alcoholic liver disease.
    Sorbi D; Boynton J; Lindor KD
    Am J Gastroenterol; 1999 Apr; 94(4):1018-22. PubMed ID: 10201476
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dulaglutide decreases plasma aminotransferases in people with Type 2 diabetes in a pattern consistent with liver fat reduction: a post hoc analysis of the AWARD programme.
    Cusi K; Sattar N; García-Pérez LE; Pavo I; Yu M; Robertson KE; Karanikas CA; Haupt A
    Diabet Med; 2018 Oct; 35(10):1434-1439. PubMed ID: 29869810
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A randomized trial to determine the change in alanine aminotransferase during 10 days of paracetamol (acetaminophen) administration in subjects who consume moderate amounts of alcohol.
    Heard K; Green JL; Bailey JE; Bogdan GM; Dart RC
    Aliment Pharmacol Ther; 2007 Jul; 26(2):283-90. PubMed ID: 17593074
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vitamin-dependent methionine metabolism and alcoholic liver disease.
    Halsted CH; Medici V
    Adv Nutr; 2011 Sep; 2(5):421-7. PubMed ID: 22332083
    [TBL] [Abstract][Full Text] [Related]  

  • 26. S-adenosyl-L-methionine in the treatment of patients with intrahepatic cholestasis of pregnancy: a randomized, double-blind, placebo-controlled study with negative results.
    Ribalta J; Reyes H; Gonzalez MC; Iglesias J; Arrese M; Poniachik J; Molina C; Segovia N
    Hepatology; 1991 Jun; 13(6):1084-9. PubMed ID: 2050326
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of a probiotic on liver aminotransferases in nonalcoholic fatty liver disease patients: a double blind randomized clinical trial.
    Aller R; De Luis DA; Izaola O; Conde R; Gonzalez Sagrado M; Primo D; De La Fuente B; Gonzalez J
    Eur Rev Med Pharmacol Sci; 2011 Sep; 15(9):1090-5. PubMed ID: 22013734
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Folate deficiency, methionine metabolism, and alcoholic liver disease.
    Halsted CH; Villanueva JA; Devlin AM
    Alcohol; 2002 Jul; 27(3):169-72. PubMed ID: 12163145
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The ratio of aspartate aminotransferase to alanine aminotransferase (AST/ALT): the correlation of value with underlying severity of alcoholic liver disease.
    Gurung RB; Purbe B; Gyawali P; Risal P
    Kathmandu Univ Med J (KUMJ); 2013; 11(43):233-6. PubMed ID: 24442172
    [TBL] [Abstract][Full Text] [Related]  

  • 30. WITHDRAWN: S-adenosyl-L-methionine for alcoholic liver diseases.
    Rambaldi A; Gluud C
    Cochrane Database Syst Rev; 2015 Nov; 2015(11):CD002235. PubMed ID: 26560497
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Methionine metabolic pathway in alcoholic liver injury.
    Kharbanda KK
    Curr Opin Clin Nutr Metab Care; 2013 Jan; 16(1):89-95. PubMed ID: 23232418
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A randomized, placebo-controlled trial of emricasan in patients with NASH and F1-F3 fibrosis.
    Harrison SA; Goodman Z; Jabbar A; Vemulapalli R; Younes ZH; Freilich B; Sheikh MY; Schattenberg JM; Kayali Z; Zivony A; Sheikh A; Garcia-Samaniego J; Satapathy SK; Therapondos G; Mena E; Schuppan D; Robinson J; Chan JL; Hagerty DT; Sanyal AJ
    J Hepatol; 2020 May; 72(5):816-827. PubMed ID: 31887369
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of Phytosomal Curcumin on Circulating Levels of Adiponectin and Leptin in Patients with Non-Alcoholic Fatty Liver Disease: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial.
    Mirhafez SR; Farimani AR; Dehhabe M; Bidkhori M; Hariri M; Ghouchani BF; Abdollahi F
    J Gastrointestin Liver Dis; 2019 Jun; 28():183-189. PubMed ID: 31204416
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Magnesium isoglycyrrhizinate in the treatment of chronic liver diseases: a randomized, double-blind, multi-doses, active drug controlled, multi-center study].
    Mao YM; Zeng MD; Chen Y; Chen CW; Fu QC; Cai X; Wu SM; Chen YG; Sun Y; Li J; Sui YH; Zhao W; Lu LG; Cao AP; Chen HZ
    Zhonghua Gan Zang Bing Za Zhi; 2009 Nov; 17(11):847-51. PubMed ID: 19958646
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dietary supplement S-adenosyl-L-methionine (AdoMet) effects on plasma homocysteine levels in healthy human subjects: a double-blind, placebo-controlled, randomized clinical trial.
    Thompson MA; Bauer BA; Loehrer LL; Cha SS; Mandrekar JN; Sood A; Wahner-Roedler DL
    J Altern Complement Med; 2009 May; 15(5):523-9. PubMed ID: 19422296
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High AST/ALT ratio may indicate advanced alcoholic liver disease rather than heavy drinking.
    Nyblom H; Berggren U; Balldin J; Olsson R
    Alcohol Alcohol; 2004; 39(4):336-9. PubMed ID: 15208167
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Multicenter clinical study about the action of Fuzheng Huayu Capsule against liver fibrosis with chronic hepatitis B].
    Liu P; Hu YY; Liu C; Xu LM; Liu CH; Sun KW; Hu DC; Yin YK; Zhou XQ; Wan MB; Cai X; Zhang ZQ; Ye J; Tang BZ; He J
    Zhong Xi Yi Jie He Xue Bao; 2003 Jul; 1(2):89-98, 102. PubMed ID: 15339577
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Norursodeoxycholic acid versus placebo in the treatment of non-alcoholic fatty liver disease: a double-blind, randomised, placebo-controlled, phase 2 dose-finding trial.
    Traussnigg S; Schattenberg JM; Demir M; Wiegand J; Geier A; Teuber G; Hofmann WP; Kremer AE; Spreda F; Kluwe J; Petersen J; Boettler T; Rainer F; Halilbasic E; Greinwald R; Pröls M; Manns MP; Fickert P; Trauner M;
    Lancet Gastroenterol Hepatol; 2019 Oct; 4(10):781-793. PubMed ID: 31345778
    [TBL] [Abstract][Full Text] [Related]  

  • 39. ACG Clinical Guideline: Evaluation of Abnormal Liver Chemistries.
    Kwo PY; Cohen SM; Lim JK
    Am J Gastroenterol; 2017 Jan; 112(1):18-35. PubMed ID: 27995906
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hepatoprotective Effects of a Proprietary Glycyrrhizin Product during Alcohol Consumption: A Randomized, Double-Blind, Placebo-Controlled, Crossover Study.
    Chigurupati H; Auddy B; Biyani M; Stohs SJ
    Phytother Res; 2016 Dec; 30(12):1943-1953. PubMed ID: 27539273
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.